E-Books durchsuchen

Chronology of Drug Development for Malaria

Scientific Challenges and Treatment Opportunities in the Face of Shifting Malaria Epidemiology

Emerging Formulation Technologies Against Malaria Resurgence

Targeted Drug Delivery for Antimalarial Therapy

The Imminent Threat of Antimalarial Drug Resistance

Current Therapies and New Drug Targets for the Future Drug Development of Drug Resistant Malaria

Assays for Antimalarial Drug Discovery

Aminoacyl‐ <fc>tRNA</fc> Synthetases as Malarial Drug Targets: A Structural Biology Perspective

Natural Products as a Source for Antimalarial Drug Development Process – An Overview

Mushroom‐Derived Products as an Alternative Antimalarial Therapeutics: A Review

Discovery and Trends of 8‐Aminoquinoline and 4‐Aminoquinoline Classes of Antimalarials

Antimalarial Activity of Novel Class of 1,3‐Benzoxaborole Derivatives Containing 1,3,4‐Oxadiazole Moiety

Recent Advances in Malaria Vaccine Development

Toll‐Like Receptor‐Based Adjuvants: A Gateway Toward Improved Malaria Vaccination

Pure <fc>TLR</fc> 7 Agonistic <fc>BBIQ</fc> is a Potential Adjuvant Against <fc><fi>Plasmodium berghei</fi> ANKA</fc> Challenge <fc><fi>In Vivo</fi></fc>

Index

Front Matter